An integrated analysis of herpes virus infections from eight randomized clinical studies of baricitinib in adults with moderate‐to‐severe atopic dermatitis-Reference-Cited by-同舟云学术

An integrated analysis of herpes virus infections from eight randomized clinical studies of baricitinib in adults with moderate‐to‐severe atopic dermatitis

Published:2022-05-18 Issue:9 Volume:36 Page:1486-1496
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Werfel T.¹²,Irvine A.D.³,Bangert C.⁴,Seneschal J.⁵^ORCID,Grond S.⁶,Cardillo T.⁶,Brinker D.⁶,Zhong J.⁷,Riedl E.⁶,Wollenberg A.⁸⁹^ORCID

Affiliation:

1. Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy Hannover Medical School Hannover Germany

2. Cluster of Excellence RESIST (EXC 2155) Hannover Medical School Hannover Germany

3. Department of Clinical Medicine Trinity College Dublin Ireland

4. Department of Dermatology Medical University of Vienna Vienna Austria

5. Department of Dermatology and Pediatric Dermatology and National Reference Center for Rare Skin Disorders Hôpital Saint‐André Bordeaux France

6. Eli Lilly and Company Indianapolis Indiana USA

7. IQVIA Durham North Carolina USA

8. Department of Dermatology and Allergy, University Hospital Ludwig Maximillian University Munich Germany

9. Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel) Department of Dermatology Brussels Belgium

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.18193

Reference24 articles.

1. Association of herpes zoster and chronic inflammatory skin disease in US inpatients

2. Eczema Herpeticum: Clinical and Pathophysiological Aspects

3. Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders

4. Association of Atopic Dermatitis With Bacterial, Fungal, Viral, and Sexually Transmitted Skin Infections

5. Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ response

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efectividad y seguridad del baricitinib en la dermatitis atópica en la práctica clínica: estudio retrospectivo multicéntrico de cuatro hospitales andaluces (España);Actas Dermo-Sifiliográficas;2024-02

2. Hohe Rezidivrate des Eczema herpeticatum bei mittelschwerer bis schwerer atopischer Dermatitis – eine TREATgermany Registeranalyse;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-12

3. Infectious adverse events in patients with atopic dermatitis treated with baricitinib;Immunotherapy;2023-12

4. High recurrence rate of eczema herpeticum in moderate/severe atopic dermatitis –TREATgermany registry analysis;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-10-09

5. Atopic Dermatitis as a Risk Factor for Herpes Zoster Infection Independent of Treatment: A Nationwide Population-Based Cohort Study;Dermatitis®;2023-06-01